Upper respiratory tract infections (URTIs) are the leading cause of acute disease worldwide and bear a substantial burden on healthcare systems.1 In the U.S., adults can expect an average of two to four non-influenza-related viral respiratory infections per year, resulting in approximately 75 million physician visits and nearly 150 million lost workdays annually.2 Additionally, ambulatory care visits account for 58.1% of URTI-related expenditures and emergency department visits add another 21.7%.3 Total U.S. spending across all respiratory diseases reaches an estimated $170.8 billion annually, and the cost to employers was approximately $112 billion per year from combined direct medical costs and lost productivity.3,4 The impact affects children at a disproportionate rate, with those under two years of age experiencing the highest rate of URTI episodes of any age group, underscoring the vulnerability of the pediatric population.1 Given the expense and time demands of physician office visits, patients often seek self-care for URTI symptoms. Community pharmacy professionals have the opportunity to serve as first-line providers for these illnesses.5 Homeopathic products for cold, flu, and respiratory symptoms continue to gain popularity among consumers seeking complementary and alternative self-care options. According to a recent projection report, the homeopathy global market is expected to increase from $15.96 billion in 2025 to $28.81 billion by 2034, reflecting a 6.78% annual growth rate over the next decade.6
This activity has been supported by an unrestricted educational grant from Boiron, USA. The company played no role in the development of this CE activity.
Target Audience: Pharmacists, Pharmacy Technicians